Food, Drug & Cosmetic Law: Policy, Pricing, and Market Strategy
This program will examine how recent developments in U.S. healthcare policy, including drug pricing reform, PBM regulation, and evolving regulatory frameworks, are influencing commercial strategy, valuation, and market behavior. The discussion will focus on how these policy shifts are beginning to shape real-world business decisions for healthcare and life sciences companies.
Speaker
Ron Lanton, Esq., Senior Partner, Lanton, Lanton & Sosa Law PLLC
President, Lanton Strategies International
Boston, MA / Washington, D.C./ Amsterdam
Start Date:
- May 27, 2026
Start Time:
- 1:00 PM
End Time:
- 2:00 PM
Areas Of Professional Practice Credit(s):
- 1.0
Total Credit(s):
- 1.0
Region:
- Virtual Participation
- Ron Lanton III, Esq. , Speaker
Format:
- Webinar
Product Code:
- 0QV61
Section Member Price:
Free
NYSBA Member Price:
Free
Join (or renew) for special member pricing
Non-Member Price:
$395.00
Sponsoring Committee Group
- Food, Drug & Cosmetic Law Section
- Committee on Continuing Legal Education
